Li, C., Zhang, J., Xue, M., Li, X., Han, F., Liu, X., . . . Chen, L. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol.
Citação norma ChicagoLi, Chenguang, et al. "SGLT2 Inhibition With Empagliflozin Attenuates Myocardial Oxidative Stress and Fibrosis in Diabetic Mice Heart." Cardiovasc Diabetol 2019.
MLA CitationLi, Chenguang, et al. "SGLT2 Inhibition With Empagliflozin Attenuates Myocardial Oxidative Stress and Fibrosis in Diabetic Mice Heart." Cardiovasc Diabetol 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.